ArticleLeukemia2025

Comparison of induction with arsenic trioxide or chemotherapy in a real-world cohort of patients with high-risk acute promyelocytic leukemia.

Delphine Lebon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.